Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2/3 1

Status

Recruiting 3Completed 3Unknown 1Active not recruiting 1

Sponsor Class

OTHER 29OTHER_GOV 5INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Keratosis, Actinic 1Disease 1Breast Neoplasms 1Biliary Tract Neoplasms 1

Interventions

pembrolizumab 241Carboplatin 170Injections 139Paclitaxel 122Gemcitabine 118Bevacizumab 117Cisplatin 108Pemetrexed 80Docetaxel 80Cyclophosphamide 74Capecitabine 69Fluorouracil 67Oxaliplatin 65Fulvestrant 60Nivolumab 55Cetuximab 53fludarabine 52Leucovorin 51130-nm albumin-bound paclitaxel 50Dexamethasone 46Rituximab 41atezolizumab 38venetoclax 35toripalimab 35Drug Therapy 35enzalutamide 32Prednisone 32Letrozole 32Irinotecan 32durvalumab 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × INDUSTRY × Control Groups × Clear all
NCT06039644 2026-03-06

To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer

GenMont Biotech Incorporation

Phase NA Recruiting
100 enrolled
Breast

Breast Neoplasms

NCT07335003 2026-01-12

Study of the Photoprotection and Prevention of Actinic Damage With Anthelios Fluide 100 KA+ UVMune 400 in Patients With Multiple Actinic Keratoses

Cosmetique Active International

Phase NA Recruiting
80 enrolled
Dermatologic

Disease, Keratosis, Actinic

NCT05065957 2025-04-30

Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer

InnoPharmax Inc.

Phase 2/3 Recruiting
180 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡